104 related articles for article (PubMed ID: 27652311)
1. Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia.
Sujobert P; Tamburini J
Mol Cell Oncol; 2016 Jul; 3(4):e1071303. PubMed ID: 27652311
[TBL] [Abstract][Full Text] [Related]
2. Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.
Sujobert P; Poulain L; Paubelle E; Zylbersztejn F; Grenier A; Lambert M; Townsend EC; Brusq JM; Nicodeme E; Decrooqc J; Nepstad I; Green AS; Mondesir J; Hospital MA; Jacque N; Christodoulou A; Desouza TA; Hermine O; Foretz M; Viollet B; Lacombe C; Mayeux P; Weinstock DM; Moura IC; Bouscary D; Tamburini J
Cell Rep; 2015 Jun; 11(9):1446-57. PubMed ID: 26004183
[TBL] [Abstract][Full Text] [Related]
3. AMPK activation by GSK621 inhibits human melanoma cells in vitro and in vivo.
Chen L; Chen Q; Deng G; Kuang S; Lian J; Wang M; Zhu H
Biochem Biophys Res Commun; 2016 Nov; 480(4):515-521. PubMed ID: 27751856
[TBL] [Abstract][Full Text] [Related]
4. GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings.
Jiang H; Liu W; Zhan SK; Pan YX; Bian LG; Sun B; Sun QF; Pan SJ
PLoS One; 2016; 11(8):e0161017. PubMed ID: 27532105
[TBL] [Abstract][Full Text] [Related]
5. AMPK activation induces immunogenic cell death in AML.
Mondesir J; Ghisi M; Poillet L; Bossong RA; Kepp O; Kroemer G; Sarry JE; Tamburini J; Lane AA
Blood Adv; 2023 Dec; 7(24):7585-7596. PubMed ID: 37903311
[TBL] [Abstract][Full Text] [Related]
6. Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts.
Liu W; Mao L; Ji F; Chen F; Hao Y; Liu G
Oncotarget; 2017 Feb; 8(6):10543-10552. PubMed ID: 28060740
[TBL] [Abstract][Full Text] [Related]
7. GSK621 attenuates oxygen glucose deprivation/re-oxygenation-induced myocardial cell injury via AMPK-dependent signaling.
Ting-Ting L; Yuan G; Jun L; Dan X; Hong-Bo T
Biochem Biophys Res Commun; 2019 Jun; 514(3):826-834. PubMed ID: 31079918
[TBL] [Abstract][Full Text] [Related]
8. Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation.
Jacquel A; Luciano F; Robert G; Auberger P
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274374
[TBL] [Abstract][Full Text] [Related]
9. Subversion of Host Responses to Energy Insufficiency by Us3 Supports Herpes Simplex Virus 1 Replication during Stress.
Vink EI; Smiley JR; Mohr I
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468873
[TBL] [Abstract][Full Text] [Related]
10. Amino acids regulate energy utilization through mammalian target of rapamycin complex 1 and adenosine monophosphate activated protein kinase pathway in porcine enterocytes.
Xiao H; Zha C; Shao F; Wang L; Tan B
Anim Nutr; 2020 Mar; 6(1):98-106. PubMed ID: 32211535
[TBL] [Abstract][Full Text] [Related]
11. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition.
Kasner MT; Mick R; Jeschke GR; Carabasi M; Filicko-O'Hara J; Flomenberg N; Frey NV; Hexner EO; Luger SM; Loren AW; Mangan JK; Wagner JL; Weiss M; Carroll M; Perl AE
Invest New Drugs; 2018 Aug; 36(4):657-666. PubMed ID: 29607465
[TBL] [Abstract][Full Text] [Related]
13. GSK621 activates AMPK signaling to inhibit LPS-induced TNFα production.
Wu YH; Li Q; Li P; Liu B
Biochem Biophys Res Commun; 2016 Nov; 480(3):289-295. PubMed ID: 27712936
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.
Chapuis N; Tamburini J; Green AS; Vignon C; Bardet V; Neyret A; Pannetier M; Willems L; Park S; Macone A; Maira SM; Ifrah N; Dreyfus F; Herault O; Lacombe C; Mayeux P; Bouscary D
Clin Cancer Res; 2010 Nov; 16(22):5424-35. PubMed ID: 20884625
[TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
17. [Co-activation of AMPK and mTORC1: a therapeutic application of synthetic lethality in acute myeloid leukemia].
Tamburini J; Poulain L; Bouscary D; Sujobert P
Med Sci (Paris); 2015 Oct; 31(10):836-9. PubMed ID: 26481022
[No Abstract] [Full Text] [Related]
18. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
Ghosh J; Kapur R
Exp Hematol; 2017 Jun; 50():13-21. PubMed ID: 28342808
[TBL] [Abstract][Full Text] [Related]
19. Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling.
Li C; Reif MM; Craige SM; Kant S; Keaney JF
Nitric Oxide; 2016 May; 55-56():45-53. PubMed ID: 26989010
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
